TORIPALIMAB

UNII: 8JXN261VVA
Preferred Substance Name: TORIPALIMAB

1924598-82-2
ANTI-PD-I MAB-SHANGHAI JUNSHI
CHS-007
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL JS001 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JS001 .KAPPA.-CHAIN, DIMER
JS001
JS-001
LOQTORZI
TAB001
TAB-001
TERIPRIZUMAB
TORIPALIMAB [INN]
TORIPALIMAB [USAN]
TORIPALIMAB [WHO-DD]
TORIPALIMAB-TPZI
TREPRIZUMAB
TRIPLEITRIUMAB
TRIPRIZUMAB
TUOYI

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

TORIPALIMAB

Synonyms and Mappings

Resources

Note